Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Dose Response of LY333334 in Japanese Postmenopausal Women With Osteoporosis

NCT00191867 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00191867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00191867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Dose Response of LY333334 in Japanese Postmenopausal Women With Osteoporosis
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2005
Completion date
March 31, 2006
Enrollment
160
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis